TeneoBio is Biotechnology in United States that focus on heavy-chain antibodies business. Founded in 2009. They cover business area such as operator, biologic, human heavy-chain, cancer, autoimmunity, infectious disease, genetically engineer animal, next-generation sequencing, bioinformatic, high-throughput vector assembly technology, large number, unique binding molecule, therapeutic target, interest, patient immune system, disorder.
2009
( 15 years old in 2024 )
Heavy-chain Antibodies
-
7999 Gateway Boulevard
Newark, CA 94560
United States
Private
operatorbiologichuman heavy-chaincancerautoimmunityinfectious diseasegenetically engineer animalnext-generation sequencingbioinformatichigh-throughput vector assembly technologylarge numberunique binding moleculetherapeutic targetinterestpatient immune systemdisorder
* We use standard office opening hours in near TeneoBio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
TeneoBio is Biotechnology business from United States that founded in 2009 (15 years old in 2024), TeneoBio business is focusing on Heavy-chain Antibodies.
TeneoBio headquarter office and corporate office address is located in 7999 Gateway Boulevard Newark, CA 94560 United States.
TeneoBio was founded in United States.
In 2024, TeneoBio is currently focus on heavy-chain antibodies sector.
Above is snippet of Google Trends for "heavy-chain antibodies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with TeneoBio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
